Using a ferromagnetic detection system before MRI may boost safety, detecting implanted or embedded items that may contraindicate the exam.
A ferromagnetic detection system may detect implanted or embedded items in patients referred for MRI examinations, according to a study published in the American Journal of Roentgenology.
Magnetic resonance images are becoming more common, particularly as clinicians try to avoid using CT scans to limit radiation exposure to their patients. However, MRI has its own risks because of ferromagnetic implants or foreign bodies that may be exposed to the powerful magnetic fields.
Researchers from University of Southern California and Loyola Marymount University in Los Angeles investigated the feasibility of using a ferromagnetic detection device to screen patients for implants and foreign objects before undergoing MRI.
Volunteers were recruited for screening with a “pillar-type” ferromagnetic detection device. Sixty-seven different implants and other objects were chosen for testing (43 pulse generators, five electronic devices, six stents, three CSF shut-off valves, three orthopedic implants, four bullets, and three “other). The volunteers were first screened without any ferromagnetic objects on their body. After confirmation of the system’s function, objects were attached to the volunteers’ body in a realistic in situ location.
The tests found 58 true-positive, four true-negative, no false-positive, and five false-negative findings for a sensitivity of 92 percent and specificity of 100 percent.
The researchers concluded that this type of screening may be used not only for detection of external ferromagnetic objects, but also for implanted or embedded items. They suggest further research to determine the system’s use in the clinical setting.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.